Liquid chromatography tandem mass spectrometry method for the quantification of rimonabant, a CB1 receptor antagonist, in human plasma

Biomedical Chromatography

Volumn 22, Issue 5, 2008, Pages 469-477

  Nirogi, Ramakrishna ^a   Kandikere, Vishwottam ^a   Mudigonda, Koteshwara ^a   Ajjala, Devender ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

Human plasma; Liquid chromatography tandem mass spectrometry; Pharmacokinetic study; Rimonabant

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; PLASMA (HUMAN);

ANALYTES; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; HUMAN PLASMA SAMPLES; HUMAN PLASMAS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; LIQUID-LIQUID EXTRACTION; PHARMACOKINETIC STUDIES; RECEPTOR ANTAGONISTS; RIMONABANT;

MASS SPECTROMETRY;

CANNABINOID 1 RECEPTOR ANTAGONIST; PROTON; RIMONABANT; SITAGLIPTIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; LIQUID LIQUID EXTRACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; STANDARD; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 44249111429     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.955     Document Type: Article

References (14)